Evidence map›Paper›PMID 30604373›Full record

Trial reportDigestive diseases and sciences2020

Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.

Zaid Bilgrami, Ameer Abutaleb, Kenechukwu Chudy-Onwugaje, Patricia Langenberg, Miguel Regueiro, David A Schwartz, J Kathleen Tracy, Leyla Ghazi, Seema A Patil, Sandra M Quezada and 6 more

Erratum issuedOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Digestive diseases and sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 8 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 8 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Remote care through telehealth for people with inflammatory bowel disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Remote Monitoring and Telemedicine in IBD: Are We There Yet?Current gastroenterology reports · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Zaid BilgramiUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Ameer AbutalebUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Kenechukwu Chudy-OnwugajeUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Patricia LangenbergUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Miguel RegueiroUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
David A SchwartzVanderbilt University School of Medicine, Nashville, TN, USA.
J Kathleen TracyUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Leyla GhaziDartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Seema A PatilUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Sandra M QuezadaUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Katharine M RussmanUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Charlene C QuinnUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
Guruprasad JambaulikarBrigham and Women's Hospital, Boston, MA, USA.
Dawn B BeaulieuVanderbilt University School of Medicine, Nashville, TN, USA.
Sara HorstVanderbilt University School of Medicine, Nashville, TN, USA.
Raymond K CrossUniversity of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA. rcross@som.umaryland.edu.
University of Maryland, Baltimore · USVanderbilt University · USBrigham and Women's Hospital · USDartmouth–Hitchcock Medical Center · USUniversity of Pittsburgh · US

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
TELEmedicine in Patients with Inflammatory Bowel Disease: TELE-IBDR01HS018975 · AHRQ · UNIVERSITY OF MARYLAND BALTIMORE · PI CROSS, RAYMOND KEITH · 2012 to 2014
$1.1M
Agency for Healthcare Research and Quality 1R01HS018975-01A1AHRQ HHS R01 HS018975NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

introductionLimitations in inflammatory bowel disease (IBD) care necessitate greater patient activation and self-efficacy, measures associated with positive health outcomes.

methodsWe assessed change in patient activation and general self-efficacy from baseline to 12 months through our TELEmedicine for IBD trial, a multicenter, randomized controlled trial consisting of a web-based monitoring system that interacts with participants via text messaging. A total of 222 adults with IBD who had experienced an IBD flare within 2 years prior to the trial were randomized into either a control arm that received standard care (SC) or an intervention arm that completed self-testing through the TELE-IBD system every other week (EOW) or weekly (W).

resultsChanges in self-efficacy scores were not significantly different between control and experimental groups. Patient activation scores were significantly different between standard care and the TELE-IBD EOW group only (p = 0.03).

conclusionsUse of remote monitoring did not improve self-efficacy or patient activation compared to routine care.

Indexed as

Patient ParticipationSelf CareSelf EfficacyTelemedicineText MessagingAdultFemaleHealth Knowledge, Attitudes, PracticeHumansInflammatory Bowel DiseasesMaleMiddle AgedTime FactorsTreatment OutcomeUnited StatesInflammatory bowel diseasePatient activationSelf-efficacyTelemedicine

Identifiers

PMID30604373
PMCPMC7883399
OpenAlexW2906752539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.